Steris PLC (NYSE:STE) Director Richard Martin Steeves Sells 5,960 Shares

Steris PLC (NYSE:STE) Director Richard Martin Steeves sold 5,960 shares of the company’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $150.75, for a total transaction of $898,470.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Richard Martin Steeves also recently made the following trade(s):

  • On Wednesday, December 4th, Richard Martin Steeves sold 5,854 shares of Steris stock. The stock was sold at an average price of $153.77, for a total transaction of $900,169.58.

Shares of STE traded up $1.99 during mid-day trading on Wednesday, hitting $154.07. The stock had a trading volume of 471,410 shares, compared to its average volume of 469,005. Steris PLC has a fifty-two week low of $99.14 and a fifty-two week high of $156.66. The company has a quick ratio of 1.86, a current ratio of 2.41 and a debt-to-equity ratio of 0.73. The company has a market cap of $12.81 billion, a PE ratio of 31.51 and a beta of 0.89. The company’s fifty day simple moving average is $145.59 and its two-hundred day simple moving average is $145.58.

Steris (NYSE:STE) last posted its quarterly earnings results on Monday, November 4th. The medical equipment provider reported $1.32 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.26 by $0.06. Steris had a return on equity of 16.15% and a net margin of 11.59%. The business had revenue of $736.84 million for the quarter, compared to analyst estimates of $717.79 million. During the same period in the prior year, the company posted $1.10 EPS. The business’s revenue was up 8.5% compared to the same quarter last year. Equities analysts expect that Steris PLC will post 5.6 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 20th. Shareholders of record on Tuesday, November 26th will be paid a dividend of $0.37 per share. The ex-dividend date is Monday, November 25th. This represents a $1.48 annualized dividend and a yield of 0.96%. Steris’s payout ratio is 30.27%.

A number of hedge funds have recently added to or reduced their stakes in STE. TrinityPoint Wealth LLC grew its position in shares of Steris by 3.4% during the 2nd quarter. TrinityPoint Wealth LLC now owns 2,267 shares of the medical equipment provider’s stock valued at $336,000 after buying an additional 75 shares during the last quarter. CWM LLC raised its stake in Steris by 130.9% during the third quarter. CWM LLC now owns 187 shares of the medical equipment provider’s stock worth $27,000 after acquiring an additional 106 shares during the period. Parallel Advisors LLC lifted its holdings in Steris by 7.6% in the third quarter. Parallel Advisors LLC now owns 1,664 shares of the medical equipment provider’s stock worth $240,000 after acquiring an additional 117 shares during the last quarter. Squar Milner Financial Services LLC lifted its holdings in Steris by 225.9% in the third quarter. Squar Milner Financial Services LLC now owns 176 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 122 shares during the last quarter. Finally, Cullen Frost Bankers Inc. lifted its holdings in Steris by 114.4% in the second quarter. Cullen Frost Bankers Inc. now owns 253 shares of the medical equipment provider’s stock worth $38,000 after acquiring an additional 135 shares during the last quarter. Hedge funds and other institutional investors own 86.77% of the company’s stock.

Separately, ValuEngine downgraded Steris from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. Steris presently has an average rating of “Buy” and a consensus price target of $148.20.

Steris Company Profile

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

See Also: What is range trading?

Insider Buying and Selling by Quarter for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.